Chinese drug developer Kintor raises $45m led by state-backed FTZ Fund

Kintor Pharmaceutical Limited, which specializes in the research and development of prostate, breast and liver cancer drugs, has raised $45 million in a new funding round led by Shanghai Free Trade Zoon Equity Fund (FTZ Fund).